[Mitochondrial benzodiazepine receptors (MBR) in association with neurological disorders]

Nihon Shinkei Seishin Yakurigaku Zasshi. 1998 Apr;18(2):49-54.
[Article in Japanese]

Abstract

Ro 5-4864, a specific agonist of the peripheral-type benzodiazepine receptor (PBR), elicited convulsions 2.6 times more potently in EL mice (an animal model of epilepsy) than in DDY mice (control animal). A binding assay revealed a 50% higher density of [3H] Ro 5-4864 binding sites in the mitochondrial fraction (i.e., mitochondrial benzodiazepine receptors; MBR) of the brain tissues in EL mice as compared with DDY mice. On an elevated plus-maze, EL mice showed fear responses similar to those increased in DDY mice after PBR stimulation, suggesting a hyperfunction of MBR underlying the abnormal behaviors of EL mice. In fluorometric studies using NG108-15 cells, Ro 5-4864 depolarized mitochondrial membranes and, possibly as a consequence of this, raised intracellular Ca2+. Finally, we propose that MBR could be a major target of therapy for various neurological disorders, so drugs such as "mitochondrial membrane stabilizers" should be developed.

Publication types

  • Review

MeSH terms

  • Animals
  • Benzodiazepinones
  • Convulsants
  • Mice
  • Mice, Mutant Strains
  • Mitochondria / physiology*
  • Receptors, GABA-A / physiology*
  • Seizures / chemically induced
  • Seizures / metabolism*

Substances

  • Benzodiazepinones
  • Convulsants
  • Receptors, GABA-A
  • 4'-chlorodiazepam